130 related articles for article (PubMed ID: 34082663)
1. A 5-gene DNA methylation signature is a promising prognostic biomarker for early-stage cervical cancer.
Chen H; Li H; Wang L; Li Y; Yang C
J Obstet Gynaecol; 2022 Feb; 42(2):327-332. PubMed ID: 34082663
[TBL] [Abstract][Full Text] [Related]
2. A 10-gene prognostic methylation signature for stage I-III cervical cancer.
Cai S; Yu X; Gu Z; Yang Q; Wen B; Sheng J; Guan R
Arch Gynecol Obstet; 2020 May; 301(5):1275-1287. PubMed ID: 32274635
[TBL] [Abstract][Full Text] [Related]
3. Identification of a methylomics-associated nomogram for predicting overall survival of stage I-II lung adenocarcinoma.
Wang H; Wei C; Pan P; Yuan F; Cheng J
Sci Rep; 2021 May; 11(1):9938. PubMed ID: 33976305
[TBL] [Abstract][Full Text] [Related]
4. A five-DNA methylation signature act as a novel prognostic biomarker in patients with ovarian serous cystadenocarcinoma.
Guo W; Zhu L; Yu M; Zhu R; Chen Q; Wang Q
Clin Epigenetics; 2018 Nov; 10(1):142. PubMed ID: 30446011
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation profiling to predict recurrence risk in stage Ι lung adenocarcinoma: Development and validation of a nomogram to clinical management.
Ma X; Cheng J; Zhao P; Li L; Tao K; Chen H
J Cell Mol Med; 2020 Jul; 24(13):7576-7589. PubMed ID: 32530136
[TBL] [Abstract][Full Text] [Related]
6. A 3-DNA methylation signature as a novel prognostic biomarker in patients with sarcoma by bioinformatics analysis.
Wang XW; Sun Q; Xu SB; Xu C; Xia CJ; Zhao QM; Zhang HH; Tan WQ; Zhang L; Yao SD
Medicine (Baltimore); 2021 May; 100(20):e26040. PubMed ID: 34011115
[TBL] [Abstract][Full Text] [Related]
7. Identification of CD28 and PTEN as novel prognostic markers for cervical cancer.
Shen F; Zheng H; Zhou L; Li W; Liu J; Xu X
J Cell Physiol; 2019 May; 234(5):7004-7011. PubMed ID: 30362552
[TBL] [Abstract][Full Text] [Related]
8. Utility of a metabolic-associated nomogram to predict the recurrence-free survival of stage I cervical cancer.
Zhang Y; Lu H; Zhang J; Wang S
Future Oncol; 2021 Apr; 17(11):1325-1337. PubMed ID: 33631974
[TBL] [Abstract][Full Text] [Related]
9. Identifying four DNA methylation gene sites signature for predicting prognosis of osteosarcoma.
Zhang X; Zheng Y; Li G; Yu C; Ji T; Miao S
Transl Cancer Res; 2020 Nov; 9(11):7299-7309. PubMed ID: 35117331
[TBL] [Abstract][Full Text] [Related]
10. Postoperative nomogram for the prediction of disease-free survival in lymph node-negative stage I-IIA cervical cancer patients treated with radical hysterectomy.
Gülseren V; Kocaer M; Çakır İ; Özdemir İA; Sancı M; Güngördük K
J Obstet Gynaecol; 2020 Jul; 40(5):699-704. PubMed ID: 31607197
[TBL] [Abstract][Full Text] [Related]
11. HPV-related methylation-based reclassification and risk stratification of cervical cancer.
Yang S; Wu Y; Wang S; Xu P; Deng Y; Wang M; Liu K; Tian T; Zhu Y; Li N; Zhou L; Dai Z; Kang H
Mol Oncol; 2020 Sep; 14(9):2124-2141. PubMed ID: 32408396
[TBL] [Abstract][Full Text] [Related]
12. Identification of Tumor Microenvironment and DNA Methylation-Related Prognostic Signature for Predicting Clinical Outcomes and Therapeutic Responses in Cervical Cancer.
Liu B; Zhai J; Wang W; Liu T; Liu C; Zhu X; Wang Q; Tian W; Zhang F
Front Mol Biosci; 2022; 9():872932. PubMed ID: 35517856
[No Abstract] [Full Text] [Related]
13. A comprehensive study of oxidative stress-related effects on the prognosis and drug therapy of cervical cancer.
Sheng N; He C; Jin X; Meng Q; Gu P; Ding S; Liu H; Xu Y
J Gene Med; 2024 Jan; 26(1):e3581. PubMed ID: 37605936
[TBL] [Abstract][Full Text] [Related]
14. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
[TBL] [Abstract][Full Text] [Related]
15. A methylomics-correlated nomogram predicts the recurrence free survival risk of kidney renal clear cell carcinoma.
Zhu X; Ma X; Wu C
Math Biosci Eng; 2021 Oct; 18(6):8559-8576. PubMed ID: 34814313
[TBL] [Abstract][Full Text] [Related]
16. A four-methylated LncRNA signature predicts survival of osteosarcoma patients based on machine learning.
Deng Y; Yuan W; Ren E; Wu Z; Zhang G; Xie Q
Genomics; 2021 Jan; 113(1 Pt 2):785-794. PubMed ID: 33069828
[TBL] [Abstract][Full Text] [Related]
17. Establishment and validation of a novel autophagy-related gene signature for patients with breast cancer.
Du JX; Chen C; Luo YH; Cai JL; Cai CZ; Xu J; Ni XJ; Zhu W
Gene; 2020 Dec; 762():144974. PubMed ID: 32707305
[TBL] [Abstract][Full Text] [Related]
18. A Two-DNA Methylation Signature to Improve Prognosis Prediction of Clear Cell Renal Cell Carcinoma.
Shi S; Ye S; Wu X; Xu M; Zhuo R; Liao Q; Xi Y
Yonsei Med J; 2019 Nov; 60(11):1013-1020. PubMed ID: 31637882
[TBL] [Abstract][Full Text] [Related]
19. Risk Stratification of Early-Stage Cervical Cancer with Intermediate-Risk Factors: Model Development and Validation Based on Machine Learning Algorithm.
Chu R; Zhang Y; Qiao X; Xie L; Chen W; Zhao Y; Xu Y; Yuan Z; Liu X; Yin A; Wang Z; Zhang Q; Yang X; Su X; Kong B; Song K
Oncologist; 2021 Dec; 26(12):e2217-e2226. PubMed ID: 34427018
[TBL] [Abstract][Full Text] [Related]
20. Identification and validation of a six-gene signature associated with glycolysis to predict the prognosis of patients with cervical cancer.
Cai L; Hu C; Yu S; Liu L; Yu X; Chen J; Liu X; Lin F; Zhang C; Li W; Yan X
BMC Cancer; 2020 Nov; 20(1):1133. PubMed ID: 33228592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]